TheEdgeResearch
Home / Stocks / ICCM

IceCure Medical Ltd (ICCM)

NASDAQ Healthcare Medical - Devices
$0.80 ▼ -19.71%
Market Cap
$1.8M
Sector
Healthcare
Industry
Medical - Devices
Beta
0.43
52-Wk Range
0.65-22.2
CEO
Eyal Shamir
Country
IL
Currency
USD

IceCure Medical Ltd operates in the Medical - Devices industry of the Healthcare sector, headquartered in Caesarea, HA, IL. The stock last traded at $0.80, down 19.71% on the session, giving a market capitalisation of $1.8M. On trailing twelve-month figures it carries a trailing P/E of -0.14, a net margin of -439.7%. Its beta of 0.43 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-0.14
Price / Sales
0.46
Price / Book
0.49
EV / EBITDA
0.34
Gross margin
34.7%
Operating margin
-213.2%
Net margin
-439.7%
Return on equity
—
Debt / equity
0.08
Current ratio
2.51
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
NASDAQ Capital Market
Employees
68
IPO date
2021-08-26
Headquarters
Caesarea, HA, IL
About IceCure Medical Ltd

Headquartered in Caesarea, Israel, and founded in 2006, IceCure Medical Ltd is a medical device enterprise dedicated to inventing, refining, and marketing innovative solutions for treating human tumors through cryoablation, a freezing process. Their primary offering, the ProSense system, provides a specialized cryoablation therapy specifically for breast tumors.

Comparable companies

IceCure Medical Ltd is most often compared with the following Healthcare names:

BDMDCTSOECORMDAIMDCXPETSSRTSTELATELOVNRX
More research on ICCM
ICCM technical analysis ICCM TheEdge Score Compare against peers
Open full interactive analysis & DCF →